KCM
AMGN icon

Kames Capital Management’s Amgen AMGN Stock Holding History

Kames Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-240,170
Closed -$27.4M – 166
2013
Q4 		$27.4M Sell
240,170
-24,285
-9% -$2.76M 0.91% 42
2013
Q3 		$29.6M Sell
264,455
-172,434
-39% -$18.7M 0.91% 34
2013
Q2 		$43.1M Buy
+436,889
New +$45.3M 1.52% 22

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Kames Capital Management's AMGN Position: Q1 2014 in Review

Kames Capital Management sold out of Amgen (AMGN) in Q1 2014, closing a stake of 240,170 shares — an estimated $27.4M sold.

Kames Capital Management first reported a position in AMGN in Q2 2013 and held it in 3 quarters. The position peaked at $43.1M in Q2 2013. 1,181 funds tracked by Wall St. Rank hold AMGN as of Q1 2014.

  • Kames Capital Management reported no remaining Amgen position as of Q1 2014 after selling out during the quarter.
  • Kames Capital Management sold 240,170 Amgen shares in Q1 2014, an estimated $27.4M.
  • Kames Capital Management first reported a position in Amgen in Q2 2013 and held it in 3 quarters.
  • Kames Capital Management's Amgen position peaked at $43.1M in Q2 2013.
  • 1,181 funds tracked by Wall St. Rank held Amgen as of Q1 2014.

Based on Kames Capital Management's 13F filing for Q1 2014, filed 1 May 2014.